Serum and cerebrospinal fluid S100B concentrations in patiens with neurocysticercosis

Brazilian Journal of Medical and Biological Research

Volumn 39, Issue 1, 2006, Pages 129-135

  Lima, J E ^a   Walz, R ^b   Tort, A ^c   Souza, D ^c   Portela, L ^c   Bianchin, M M ^a   Takayanagui, O M ^a   Leite, J P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Albumin quotient; Cerebrospinal fluid; Glial marker; Neurocysticercocis; S100B

Indexed keywords

ALBUMIN; PROTEIN S100B;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CYST; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLIA; HUMAN; MALE; MEMBRANE PERMEABILITY; NEUROCYSTICERCOSIS; NEUROIMAGING; PARENCHYMA; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL;

EID: 30744467159     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2006000100015     Document Type: Article

References (39)

1. Els T, Bruckmann J, Rohn G et al. (2001). Spermidine: A predictor for neurological outcome and infarct size in focal cerebral ischemia? Stroke, 32: 43-46.
2. Ingebrigtsen T & Romner B (2002). Biochemical serum markers of traumatic brain injury. Journal of Trauma, 52: 798-808.
3. Green AJ, Thompson EJ, Stewart GE et al. (2001). Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease. Journal of Neurology, Neurosurgery, and Psychiatry, 70: 744-748.
4. Lima JE, Takayanagui OM, Garcia LV et al. (2004). Use of neuronspecific enolase for assessing the severity and outcome in patients with neurological disorders. Brazilian Journal of Medical and Biological Research, 37: 19-26.
5. Studahl M, Rosengren L, Gunther G et al. (2000). Difference in pathogenesis between herpes simplex virus type 1 encephalitis and tick-borne encephalitis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction. Journal of Neurology, 247: 636-642.
6. Kleine TO, Benes L & Zofel P (2003). Studies of the brain specificity of S100B and neuron-specific enolase (NSE) in blood serum of acute care patients. Brain Research Bulletin, 61: 265-279.
7. Goncalves DS, Lenz G, Karl J at al. (2000). Extracellular S1008 protein modulates ERK in astrocyte cultures. NeutoReport, 11: 807-809.
8. Wong CH, Rooney SJ & Bonser RS (1999). S-100beta release in hypothermic circulatory arrest and coronary artery surgery. Annals of Thoracic Surgery, 67: 1911-1914, Discussion 1919-1921.
9. Fassbender K, Schmidt R, Schreiner A et al. (1997). Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke. Journal of the Neurological Sciences, 148: 101-105.
10. Martens P, Raabe A & Johnsson P (1998). Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia. Stroke, 29: 2363-2366.
11. Georgiadis D, Berger A, Kowatschev E et al. (2000). Predictive value of S-100beta and neuron-specific enolase serum levels for adverse neurologic outcome after cardiac surgery. Journal of Thoracic and Cardiovascular Surgery, 119: 138-147.
12. Unden J, Chrlstensson B, Bellner J et al. (2004). Serum S100B levels In patients with cerebral and extracerebral infectious disease. Scandinavian Journal of Infectious Diseases, 36: 10-13.
13. Wallin MT & Kurtzke JF '(2004). Neurocysticercosis in the United States: review of an important emerging infection. Neurology, 63: 1559-1564.
14. Garcia HH, Gonzalez AE, Evans CA et al. (2003). Taenia sollium cysticercosis. Lancet, 362: 547-556.
15. White Jr AC (2000). Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management. Annual Review of Medicine 51: 187-206.
16. Carpio A (2002). Neurocystcercosis: an update. Lancet Infectious Diseases, 2: 751-762.
17. Lima JE, Takayanagui OM, Garcia LV ot al. (2004). Neuron-specific enolase in patients with neurocysticercosis. Journal of the Neurological Sciences, 217: 31-35.
18. Del Brutto OH, Rajshekhar V, White Jr AC et al. (2001). Proposed diagnostic criteria for neurocysticercosis. Neurology, 57: 177-183.
19. Carpio A, Placenda M, Santillan F et al. (1994). A proposal for classification of neurocysticercosis. Canadian Journal of Neurological Sciences, 21: 43-47.
20. Link H & Tibbling G (1977). Principles of albumin and IgG analyses in neurological disorders. II. Relation of the concentration of the proteins in serum and cerebrospinal fluid. Scandinavian Journal of Clinical and Laboratory Investigation, 37: 391-396.
21. Tibbling G, Link H & Ohman S (1977). Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scandinavian Journal of Clinical and Laboratory Investigation, 37: 385-390.
22. Missler U, Wiesmann M, Ehlermann P at al. (2000). Validation and comparison of two solid-phase immunoassays for the quantification of S-100B in human blood. Clinical Chemistty, 46: 993-996.
23. Cardona AE, Gonzalez PA & Toole JM (2003). CC chemokines mediate leukocyte trafficking into the central nervous system during murine neurocysticercosis: role of gamma delta T cells in amplification of the host immune response. Infection and Immunity, 71: 2634-2642.
24. Londono DP, Alvarez JI, Trujillo J et al. (2002). The inflammatory cell infiltrates in porcine cysticercosis: immunohistochemical analysis during various stages of infection. Veterinary Parasitology, 109: 249-259.
25. Lopez-Marin LM, Montrozier H, Lemassu A et al. (2002). Structure and antigenicity of the major glycolipid from Taenia sollum cysticerci. Molecular and Biochemical Parasitology, 119: 33-42.
26. Kristensson K, Mhlanga JD & Bentivoglio M (2002). Parasites and the brain: neuroinvasion, immunopathogenesis and neuronal dysfunctions. Current Topics in Microbiology and Immunology, 265: 227-257.
27. Bueno EC, dos Ramos Machado L, Livramento JA et al. (2004). Cellular immune response of patients with neurocysticercosis (inflammatory and non-inflammatory phases). Acts Tropica, 91: 205-213.
28. Chavarria A, Fleury A, Garcia E et al. (2005). Relationship between the clinical heterogeneity of neurocysticercosis and the immune-inflammatory profiles. Clinical Immunology 116: 271-278.
29. Robinson P, Atmar RL, Lewis DE ot al. (1997). Granuloma cytokines in murine cysticercosis. Infection and Immunity 65: 2925-2931.
30. Restrepo BI, Alvarez JI, Castano JA et al. (2001). Brain granulomas in neurocysticercosis patients are associated with a Th1 and Th2 profile. Infection and Immunity, 69: 4554-4560.
31. Medina-Escutia E, Morales-Lopez Z, Proano JV et al. (2001). Cellular immune response and Th1/Th2 cytokines in human neurocysticercosis: lack of immune suppression. Journal of Parasitology, 87: 587-590.
32. Ying Wang J, Peruzzi F, Lassak A et al. (2003). Neuroprotective effects of IGF-I against TNFalpha-induced neuronal damage in HIV-associated dementia. Virology, 305: 66-76.
33. Kerschensteiner M, Stadelmann C, Dechant G et al. (2003). Neurotrophic cross-talk between the nervous and immune systems: Implications for neurological diseases. Annals of Neurology, 53: 292-304.
34. Wolf SA, Fisher J, Bachmann I et al. (2002). Neuroprotection by T-cells depends on their subtype and activation state. Journal of Neuroimmunology, 133: 72-80.
35. Portela LV, Tort AB, Walz R et al. (2003). Interictal serum S100B levels in chronic neurocysticercosis and idiopathic epilepsy. Acta Neurologica Scandinavica, 108: 424-427.
36. Webbe G (1994). Human cysticercosis: parasitology, pathology, clinical manifestations and available treatment. Pharmacology and Therapeutics, 64: 175-200.
37. Agapejev 8 (1996). Epidemiology of neurocysticercosis in Brazil. Revista do Instituto de Medicine Tropical de São Paulo, 38: 207-216.
38. Vazquez V & Sotelo J (1992). The course of seizures after treatment for cerebral cysticercosis. New England Journal of Medicine, 327: 696-701.
39. Del Brutto OH, Garcia E, Talamas O et al. (1988). Sex-related severity of inflammation in parenchymal brain cysticercosis. Archives of Internal Medicine, 148: 544-546.